Hcv vaccinations

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/29 (2006.01) A61K 39/39 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2645832

The invention relates to a method for preventing or treating Hepatitis C Virus (HCV) infections, wherein a HCV vaccine comprising an effective amount of at least one HCV T-cell antigen and a polycationic compound comprising peptide bonds is administered to a human individual bi-weekly at least 3 times.

La présente invention concerne un procédé de prévention ou de traitement des infections par le virus de l'hépatite C (Hepatitis C Virus; HCV) selon lequel un vaccin anti-HCV comprenant une quantité efficace d'au moins un antigène de lymphocyte T de HCV et un composé polycationique comprenant des liaisons peptidiques est administré à un individu humain deux fois par semaines au moins 3 fois.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hcv vaccinations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hcv vaccinations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcv vaccinations will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1686509

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.